Arbeitspapier

The Mitigating Role of Prescription Drug Monitoring Programs in the Abuse of Prescription Drugs

In response to the epidemic of prescription-drug abuse, now 49 US states have passed legislation to establish Prescription Drug Monitoring Programs (PDMPs). These programs track controlled-substance prescribing and usage behavior in an effort to improve patient outcomes and identify and preempt access by drug abusers. We exploit variation in the timing of implementation across states to identify the effectiveness of PDMPs on reducing opioid abuse. In particular, by considering the role of specific program attributes we offer the strongest evidence to date of the potential for PDMP-type policy to decrease opioid-related treatment admissions. We also consider heterogeneity across intensity and tenure of use, which reveals that the largest gains are coming from reductions in the number of less-attached users. Overall, these results have important implications for the effective re-design of PDMP policy.

Sprache
Englisch

Erschienen in
Series: IZA Discussion Papers ; No. 10990

Klassifikation
Wirtschaft
Health Behavior
Health: Government Policy; Regulation; Public Health
Illegal Behavior and the Enforcement of Law
Thema
prescription drug
drug treatment
opioid
abuse

Ereignis
Geistige Schöpfung
(wer)
Birk, Erica G.
Waddell, Glen R.
Ereignis
Veröffentlichung
(wer)
Institute of Labor Economics (IZA)
(wo)
Bonn
(wann)
2017

Handle
Letzte Aktualisierung
10.03.2025, 11:42 MEZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.

Objekttyp

  • Arbeitspapier

Beteiligte

  • Birk, Erica G.
  • Waddell, Glen R.
  • Institute of Labor Economics (IZA)

Entstanden

  • 2017

Ähnliche Objekte (12)